Biopharmaceutical company
Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH) Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH)
HCR - Health Issues PHA - Pharmacy
25 - Defense, Dept of (DOD) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 31 - Navy, Dept of 1 - SENATE 25 - Defense, Dept of (DOD) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 31 - Navy, Dept of 1 - SENATE
BUCHANAN INGERSOLL & ROONEY PC
1700 K Street, NW, Suite 300, Washington, DC, 20006, US
JAMES C WILTRAUT MICHAEL P STRAZZELLA KYLE A DARBY MICHAEL P STRAZZELLA JAMES C WILTRAUT KYLE A DARBY